Close Phone: (858) 882-2800
Close Phone: (858) 882-2800
15 September 2017
NEW YORK, Sept 15, 2017 – Intermountain Precision Genomics’ RxMatch Antidepressant Panel, announced last week, is the lab’s first pharmacogenomics test intended to help physicians use DNA to find the right antidepressants to prescribe to patients. It is also the initial step in a strategy to grow beyond precision oncology and offer genomic assays targeting a wider array of diseases.